Altimmune, Inc. (ALT) Tops Q1 EPS by 6c

Altimmune, Inc. (NASDAQ: ALT) reported Q1 EPS of ($0.18), $0.06 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.

You May Also Be Interested In

• Four key things investors will watch in Nvidia's earnings next week
• AMCON Distributing to dual-list on NYSE Texas exchange
• Leap Therapeutics publishes Phase 2 colorectal cancer study results